Senti Biosciences Analyst Ratings
Senti Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 663.36% | Chardan Capital | → $6 | Reiterates | Buy → Buy |
| 05/11/2023 | 663.36% | Chardan Capital | $7 → $6 | Maintains | Buy |
| 03/24/2023 | 154.45% | Morgan Stanley | $3 → $2 | Maintains | Equal-Weight |
| 03/23/2023 | 790.59% | Chardan Capital | $8 → $7 | Maintains | Buy |
| 01/30/2023 | 917.81% | Chardan Capital | $12 → $8 | Maintains | Buy |
| 01/27/2023 | 281.68% | Morgan Stanley | $7.5 → $3 | Maintains | Equal-Weight |
| 12/16/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 10/07/2022 | 854.2% | Morgan Stanley | → $7.5 | Initiates Coverage On | → Equal-Weight |
| 09/29/2022 | 790.59% | B of A Securities | → $7 | Initiates Coverage On | → Buy |
| 09/23/2022 | 1426.72% | Chardan Capital | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/15/2023 | 663.36% | 查丹资本 | → 6 美元 | 重申 | 购买 → 购买 |
| 05/11/2023 | 663.36% | 查丹资本 | 7 美元 → 6 美元 | 维护 | 购买 |
| 2023 年 3 月 24 日 | 154.45% | 摩根士丹利 | 3 美元 → 2 美元 | 维护 | 重量相等 |
| 03/23/2023 | 790.59% | 查丹资本 | 8 美元 → 7 美元 | 维护 | 购买 |
| 01/30/2023 | 917.81% | 查丹资本 | 12 美元 → 8 美元 | 维护 | 购买 |
| 01/27/2023 | 281.68% | 摩根士丹利 | 7.5 美元 → 3 美元 | 维护 | 重量相等 |
| 2022 年 12 月 16 日 | — | 摩根大通 | 启动覆盖范围开启 | → 中立 | |
| 2022 年 7 月 10 日 | 854.2% | 摩根士丹利 | → 7.5 美元 | 启动覆盖范围开启 | → 重量相等 |
| 2022 年 9 月 29 日 | 790.59% | B of A 类证券 | → 7 美元 | 启动覆盖范围开启 | → 购买 |
| 09/23/2022 | 1426.72% | 查丹资本 | → 12 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for Senti Biosciences (SNTI)?
Senti Biosciences（SNTI）的目标价格是多少？
The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by Chardan Capital on August 15, 2023. The analyst firm set a price target for $6.00 expecting SNTI to rise to within 12 months (a possible 663.36% upside). 10 analyst firms have reported ratings in the last year.
Chardan Capital于2023年8月15日公布了Senti Biosciences（纳斯达克股票代码：SNTI）的最新目标股价。这家分析公司将目标股价定为6.00美元，预计SNTI将在12个月内升至663.36％（可能上涨663.36％）。去年有10家分析公司公布了评级。
What is the most recent analyst rating for Senti Biosciences (SNTI)?
Senti Biosciences（SNTI）的最新分析师评级是多少？
The latest analyst rating for Senti Biosciences (NASDAQ: SNTI) was provided by Chardan Capital, and Senti Biosciences reiterated their buy rating.
Senti Biosciences（纳斯达克股票代码：SNTI）的最新分析师评级由Chardan Capital提供，Senti Biosciences重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Senti Biosciences (SNTI)?
Senti Biosciences（SNTI）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Senti Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Senti Biosciences was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与Senti Biosciences的高管和客户交谈以及听取财报电话会议）后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Senti Biosciences的最后一次评级是在2023年8月15日提交的，因此你应该预计下一个评级将在2024年8月15日左右公布。
Is the Analyst Rating Senti Biosciences (SNTI) correct?
分析师对森蒂生物科学（SNTI）的评级是否正确？
While ratings are subjective and will change, the latest Senti Biosciences (SNTI) rating was a reiterated with a price target of $0.00 to $6.00. The current price Senti Biosciences (SNTI) is trading at is $0.79, which is within the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Senti Biosciences（SNTI）评级得到了重申，目标股价为0.00美元至6.00美元。Senti Biosciences（SNTI）目前的交易价格为0.79美元，在分析师的预测区间内。